Xenetic Biosciences financial statements

제네틱 바이오사이언시스NASDAQ:XBIO · Nasdaq · Healthcare
$2.21+4.25%
2026-10-07 close · prelim

Xenetic Biosciences's published financial data is dated 2026-10-04. 2024 revenue was $3M. 2024 operating profit was −$4M.

Reported results

Xenetic Biosciences notifications

Quantus Signal · live data · not investment advice · Privacy Policy